Studies on the susceptibility of pathogenic Nocardia to macrolide antibiotics, chalcomycin and tylosin, showed that most of the Nocardia species examined were highly resistant to both antibiotics, although N. nova was moderately susceptible. N. asteroides IFM0339 converted these macrolides into inactive metabolites by glycosylation at 2'-OH or glycosylation and reduction of the 20-formyl group. The structures of the metabolites were determined from Our studies on the susceptibility of 75 clinical isolates of Nocardia species to macrolide antibiotics (rokitamycin, midecamycin and erythromycin) revealed species-specific drug resistance patterns, most of which involved metabolic inactivation of the drugs.1} Depending on the Nocardia species (N. asteroides, N. farcinica, N. brasiliensis, N. otitidiscaviarum and N. nova) used, rokitamycin and midecamycin were reduced at the 18-formyl group (18-dihydrorokitamycin and 1 8-dihydromidecamycin), phosphorylated and reduced (1 8-dihydro-2'-0-phosphorylrokitamycin and 1 8-dihydro-2 '-0-phosphorylmidecamycin), or deacylated (3 "-de-^-propionyl-4"-de-f2-butyrylrokitamycin, 4"-de-ft-butyrylrokitamycin, or 4"-de-ft-propionylmidecamycin).
Erythromycin was phosphorylated (2'-O-phosphorylerythromycin) or glycosylated (2'-[0-(/}-D-glucopyranosyl)]erythromycin).2)
Glycosylation of 2'-OH of desosamine in erythromycin was found only in the case of the inactivation by N. asteroides IFM 0339 strain.
pp. 157 -165 These results prompted us to study if other macrolide antibiotics, with different sugar componentson the lactone ring, were inactivated by Nocardia species. Chalcomycin (I)3' 4) which contains D-mycinose and a neutral sugar, D-chalcose, instead of a basic sugar, D-desosamine, and tylosin (3)5' 6) which contains D-mycinose, D-mycaminose and L-mycarose, were selected for this purpose. Here, we report the drug-susceptibility patterns of five Nocardia species to both antibiotics, and the elucidation of a resistance mechanismthrough the structural determination of the inactivated macrolides.
Experimental General lU and 13C NMRspectra were measured in CDC13 at 25°C on a JEOL ALPHA-500NMRspectrometer at 500 double-focusing mass spectrometer with a JMS-DA7000 data system. The ion acceleration voltage was lOkV, and the fast-atom xenon gas was accelerated at a voltage of 6 kV m-Nitrobenzyl alcohol was used as the matrix.
Chemicals
Chalcomycin and tylosin were obtained from Sigma Chemical Co.
Microorganisms and Culture Conditions
Twenty-eight strains of five pathogenic species (N. asteroides, N. brasiliensis, N. farcinica, N. nova and N.
otitidiscaviarum), including the type strains, were used. Matured seed cultures were prepared by the method previously described^and used as seed inocula for the inactivation or MICexperiments. MICs were determined by an agar dilution method using brain heart infusion agar (BHI medium and 5.0mg of TIP-0339-2 (5) were obtained, respectively. The incubation, extraction and purification were repeated, and 56mg of2, 9mg of4, and 17mg of5 were obtained.
The Rf values of 1 and 2 on a silica gel TLC plate developed with EtOAc-Me2CO (3 : 1) were 0.79 and 0.16, and those of 3, 4 and 5 developed with EtOAc-MeOH (3 : 1) were 0.63, 0.20 and 0.26, respectively.
Results

Susceptibility to Chalcomycin and Tylosin and Inactivation Profiles of Five Nocardia species
The susceptibility of pathogenic Nocardia to chalcomycin (1) and tylosin (3) was examined using erythromycin as a reference drug (Table 1) . Among five Nocardia species tested, N asteroides, N brasiliensis, N farcinica and N otitidiscaviarum were highly resistant to 1 and 3 as well as to the reference drug erythromycin; except for a few strains, MICvalues were greater than 100^g/ml. On the other hand, N nova showed a different susceptibility pattern to macrolide antibiotics. Although the MICvalues ofN nova against chalcomycin were more than 100^g/ml, the species was moderately susceptible to tylosin, with MIC values of 3.1 to 25/ig/ml. All strains ofN nova were also susceptible to the reference erythromycin. These results confirmed our previous finding that pathogenic Nocardia show species-specific drug susceptibility patterns, and N. nova is the most susceptible species to macrolides tested hitherto. 1}
Inactivation of Chalcomycin and Tylosin by N. asteroides IFM 0339
Amongthe susceptible strains to chalcomycin (1) and tylosin (3), only N. asteroides IFM 0339 converted 1 to 2, and 3 to 4 and 5. Antimicrobial activities of the products were measured by the size of the inhibition zone on Bacillus subtilis PCI 219 using paper disc12) ( Table 2 ). These data indicate that the products 2, 4 and 5 lack antimicrobial activity.
It is interesting that the higher MICvalues of Nocardia species against 1 and 3 ( 
Inactivation ability was monitored by bioassay using Bacillus subtilis PC1 219 to the presence of other resistance mechanisms. 
The structures of 2, 4 and 5 were determined by comparison of the MS and NMR data with those of chalcomycin (1) and tylosin (3) (Fig. 1) . The 13C NMR signals of 113), and the !H and 13C NMRsignals of3 have been assigned,13~17) although some ambiguities remain. In this work, we present our assignment of the !H and 13C NMRsignals of1 and 3 in CDC13 at 25°C (Tables 4 and 5) . FAB-MSdata of 2 indicated the molecular weight to be 862, and the molecular formula was determined by HRFAB-MSto be C41H66O19. This product was assumed to be glycosylated chalcomycin [(Mj +C^HjqC^), where Ml is the MWof chalcomycin] (Table 3) . Similarly, the molecular (Tables 4 and 5 ). The presence of the /3-D-glucopyranose moiety was indicated by signals at <5C 105.2 (Glu-1), 75.5 (Glu-2), 75.9 (Glu-3), 70.4 (Glu-4), 76.2 (Glu-5) and 62.6 ppm, and at 5H 4.47 (Glu-1), 3.34 (Glu-2), 3.57 (Glu-3), 3.51 (Glu-4), 3.38 (Glu-5), ppm.18~20) The presence of the /3-D-glucopyranose moiety was confirmed by a TOCSY experiment. As expected, correlations of H-Glul to H-Glu2~H-Glu6 were observed.7'8-* The site of glycosylation was determined by PFG-HMBCcorrelation of H-2' with C-Glul, and H-Glul with C-2'. The down field shift of the C-2' signal (ASC: 7.9 ppm) relative to that of 1 is also in accord with glycosylation at 2'-OH.2) No other significant differences were observed in the NMRspectra of 2 and chalcomycin 1, indicating that the remaining structures of these two FEB. 2001 compoundsare the same. (Glu-4), 3.35 (Glu-5), 3.79 and 3.86 (Glu-6) ppm. The 13C-chemical shift values of Glul~Glu6 of 5 were very similar to those of 2. The glycosylation at 2'-OH was indicated by the shift of the C-2' signal in 5 from that of tylosin (3) (ASC\ 9.0 ppm). The glycosylation site was determined by a NOESYexperiment: NOEwas observed between H-Glul and H-2\ Attempts to correlate H-2' with C-Glul and HGlul with C-2' by PFG-HMBCwere unsuccessful The signals due to the other protons and carbons in the spectra of 5 were similar to those of 3, indicating that the remaining structure was unchanged.
The structure of 4 was determined to be 20-dihydro-2'-
by comparing the 13C NMR (Table 4) and !H NMRdata with those of 5. (1), CHIP-0339 (2), tylosin (3), TIP-0339-1 (4) and TIP-0339-2 (5) in CDC13 (Reference value: <5C 77.0 ppm of chloroform). The signals due to the other carbons in the spectrum of 4 were similar to those of 5, indicating that the remaining structure was unchanged.
Discussion
Wefound that the susceptibility of pathogenic Nocardia to chalcomycin (1) and tylosin (3) was species-specific, and that N. asteroides IFM 0339 inactivated chalcomycin (1) and tylosin (3) antibiotics has not been determined, but our data clearly showed that 2'-OH ofmycaminose in tylosin (3) and that of chalcose in chalcomycin (1) were glycosylated.
Glycosylation of 1 and 3 with galactose was excluded by a TOCSYexperiment on CHIP-0339 (2) as described above; correlation of H-Glul with only H-Glu2~H-Glu-4 would have been observed for the /3-D-galactopyranosyl derivative. 28)
Wehave reported that some strains of TV. brasiliensis and N. pseudobrasiliensis produce novel antibiotics such as brasilicardin A, brasilidine A, brasilinolides, and nocardicyclins.29~32) In the course of our continuing search for antibiotics from pathogenic Nocardia isolated from clinical sources, we found that N. brasiliensis IFM 0466 strain produces macrolide antibiotics such as 32-membered brasilinolides.31} In addition, our recent study showed that this N. brasiliensis IFM 0466 strain is also a producer of erythromycins.33) We confirmed that the strain has glycosylation activity for the 2'-OH group of FEB. 2001 erythromycins (data not shown). Considering that antibiotic-producing strains should have inactivation enzymes to protect themselves from their own produced antibiotics, it would be interesting to know whether the antibiotic-inactivation enzyme of N. brasiliensis IFM 0466 is also responsible for the biosynthesis of erythromycin.
